{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:49Z","timestamp":1792661209787,"version":"4.5.0"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1213\/ane.0000000000001045","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T11:05:14Z","timestamp":1450436714000},"page":"194-201","source":"Crossref","is-referenced-by-count":100,"title":["Methylene Blue"],"prefix":"10.1213","volume":"122","author":[{"given":"Leila","family":"Hosseinian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210902","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock.","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-29-20210902","first-page":"619","article-title":"Vasoplegic syndrome after open heart surgery.","volume":"39","author":"Gomes","year":"1998","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"R3-29-20210902","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/CS20120668","article-title":"Septic shock: desperately seeking treatment.","volume":"126","author":"Huet","year":"2014","journal-title":"Clin Sci"},{"key":"R4-29-20210902","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R5-29-20210902","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.","volume":"116","author":"Argenziano","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-29-20210902","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00134-011-2148-x","article-title":"Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.","volume":"37","author":"Morelli","year":"2011","journal-title":"Intensive Care Med"},{"key":"R7-29-20210902","doi-asserted-by":"crossref","first-page":"R232","DOI":"10.1186\/cc9387","article-title":"Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study.","volume":"14","author":"Morelli","year":"2010","journal-title":"Crit Care"},{"key":"R8-29-20210902","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003246-199502000-00010","article-title":"Methylene blue administration in septic shock: a clinical trial.","volume":"23","author":"Preiser","year":"1995","journal-title":"Crit Care Med"},{"key":"R10-29-20210902","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.jvca.2008.07.015","article-title":"Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.","volume":"24","author":"Fischer","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R11-29-20210902","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1053-0770(97)90006-9","article-title":"Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass.","volume":"11","author":"Myles","year":"1997","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R13-29-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/FPC.0b013e32836498f4","article-title":"PharmGKB summary: methylene blue pathway.","volume":"23","author":"McDonagh","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"R14-29-20210902","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2044.2005.04185.x","article-title":"Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.","volume":"60","author":"Faber","year":"2005","journal-title":"Anaesthesia"},{"key":"R15-29-20210902","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue.","volume":"56","author":"Peter","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R18-29-20210902","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","article-title":"Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase I alpha.","volume":"286","author":"Surks","year":"1999","journal-title":"Science"},{"key":"R19-29-20210902","first-page":"1835","article-title":"Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.","volume":"22","author":"Busse","year":"1990","journal-title":"FEBS Lett"},{"key":"R20-29-20210902","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","article-title":"Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.","volume":"87","author":"Bredt","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-29-20210902","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1016\/S0021-9258(18)38112-2","article-title":"N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine.","volume":"266","author":"Stuehr","year":"1991","journal-title":"J Biol Chem"},{"key":"R22-29-20210902","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1073\/pnas.87.9.3629","article-title":"NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.","volume":"87","author":"Kilbourn","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-29-20210902","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/0006-291X(90)91565-A","article-title":"Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.","volume":"172","author":"Kilbourn","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-29-20210902","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/00003246-199411000-00020","article-title":"NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.","volume":"22","author":"Kilbourn","year":"1994","journal-title":"Crit Care Med"},{"key":"R25-29-20210902","first-page":"437","article-title":"NO in septic shock.","volume":"1411","author":"Titheradge","year":"1999","journal-title":"Biochem Biophys Acta"},{"key":"R26-29-20210902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00024382-200006000-00001","article-title":"Molecular regulation of the human inducible NO synthase (iNOS) gene.","volume":"13","author":"Taylor","year":"2000","journal-title":"Shock"},{"key":"R27-29-20210902","first-page":"77","article-title":"Evidence of increased nitric oxide production in patients with the sepsis syndrome.","volume":"41","author":"Evans","year":"1993","journal-title":"Circ Shock"},{"key":"R28-29-20210902","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"R29-29-20210902","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1053-0770(97)90106-3","article-title":"The inflammatory response to cardiopulmonary bypass.","volume":"11","author":"Miller","year":"1997","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R31-29-20210902","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.RES.74.6.1121","article-title":"Methylene blue reverses endotoxin-induced hypotension.","volume":"74","author":"Keaney","year":"1994","journal-title":"Circ Res"},{"key":"R32-29-20210902","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0006-2952(93)90072-5","article-title":"Inhibition of nitric oxide synthesis by methylene blue.","volume":"45","author":"Mayer","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"R33-29-20210902","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0003-9861(82)90335-6","article-title":"Purification and properties of heme-deficient hepatic soluble guanylate cyclase: effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX.","volume":"218","author":"Olstein","year":"1982","journal-title":"Arch Biochem Biophys"},{"key":"R34-29-20210902","first-page":"367","article-title":"Nitric oxide inhibition in the treatment of septic shock.","volume":"45","author":"Hata","year":"1993","journal-title":"Crit Car Med"},{"key":"R35-29-20210902","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1139\/y81-025","article-title":"Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.","volume":"59","author":"Gruetter","year":"1981","journal-title":"Can J Physiol Pharmacol"},{"key":"R36-29-20210902","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/138945012802002348","article-title":"Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview.","volume":"13","author":"Evora","year":"2012","journal-title":"Curr Drug Targets"},{"key":"R37-29-20210902","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.179.1.71","article-title":"Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.","volume":"179","author":"Beasley","year":"1994","journal-title":"J Exp Med"},{"key":"R39-29-20210902","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s001340050372","article-title":"Left ventricular systolic and diastolic function in septic shock.","volume":"23","author":"Poelaert","year":"1997","journal-title":"Intensive Care Med"},{"key":"R40-29-20210902","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/jmcc.1997.0592","article-title":"Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy.","volume":"30","author":"Francis","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"R41-29-20210902","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0008-6363(98)00314-9","article-title":"Regulation of basal myocardial function by NO.","volume":"41","author":"Kojda","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R42-29-20210902","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1631560","article-title":"Negative inotropic effects of cytokines on the heart mediated by nitric oxide.","volume":"257","author":"Finkel","year":"1992","journal-title":"Science"},{"key":"R43-29-20210902","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00003246-199508000-00009","article-title":"Methylene blue increases myocardial function in septic shock.","volume":"23","author":"Daemen-Gubbels","year":"1995","journal-title":"Crit Care Med"},{"key":"R44-29-20210902","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000096007","article-title":"Methylene blue decreases ischemia-reperfusion (IR)-induced spinal cord injury: an in vivo study in an IR rabbit model.","volume":"38","author":"Bardakci","year":"2006","journal-title":"Eur Surg Res"},{"key":"R45-29-20210902","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0022-5223(94)70355-8","article-title":"Vasoplegic syndrome: a new dilemma.","volume":"107","author":"Gomes","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R46-29-20210902","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/0003-4975(96)00055-0","article-title":"Systemic inflammatory response syndrome after cardiac operations.","volume":"61","author":"Cremer","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R47-29-20210902","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5223(19)39061-0","article-title":"Complement and the damaging effects of cardiopulmonary bypass.","volume":"86","author":"Kirklin","year":"1983","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R49-29-20210902","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"R50-29-20210902","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function.","volume":"71","author":"Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R52-29-20210902","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.","volume":"15","author":"Carrel","year":"2000","journal-title":"J Card Surg"},{"key":"R53-29-20210902","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for vasoplegia syndrome following cardiac transplantation.","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"R54-29-20210902","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"R55-29-20210902","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.athoracsur.2006.08.041","article-title":"Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review.","volume":"83","author":"Egi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R56-29-20210902","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jocs.12242","article-title":"Vasopressin induces rectosigmoidal mucosal ischemia during cardiopulmonary bypass.","volume":"29","author":"Bomberg","year":"2014","journal-title":"J Card Surg"},{"key":"R57-29-20210902","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","article-title":"Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.","volume":"31","author":"Dunser","year":"2003","journal-title":"Crit Care Med"},{"key":"R58-29-20210902","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01694349","article-title":"Symmetrical peripheral gangrene: association with noradrenaline administration.","volume":"18","author":"Hayes","year":"1992","journal-title":"Intensive Care Med"},{"key":"R59-29-20210902","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2006.01963.x","article-title":"Extensive skin necrosis following use of noradrenaline and dopamine.","volume":"21","author":"Bonamigo","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R60-29-20210902","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3904\/kjim.2006.21.4.287","article-title":"Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock.","volume":"21","author":"Kim","year":"2006","journal-title":"Korean J Intern Med"},{"key":"R61-29-20210902","first-page":"1212","article-title":"Methylene blue administration in SIRS after cardiac operations.","volume":"63","author":"Evora","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"R63-29-20210902","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management.","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R65-29-20210902","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1067\/mtc.2003.140","article-title":"Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.","volume":"125","author":"Grayling","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R66-29-20210902","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jtcvs.2003.09.019","article-title":"Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.","volume":"127","author":"Sparicio","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R67-29-20210902","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"R69-29-20210902","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jtcvs.2012.07.030","article-title":"The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature.","volume":"144","author":"Grubb","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R70-29-20210902","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0033-3182(10)70685-X","article-title":"The role of methylene blue in serotonin syndrome: a systematic review.","volume":"51","author":"Ng","year":"2010","journal-title":"Psychosomatics"},{"key":"R72-29-20210902","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock.","volume":"27","author":"Weiner","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R73-29-20210902","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.jvca.2013.09.009","article-title":"Methylene blue should be relegated to rescue use and not as first-line therapy cannot become a paradigm.","volume":"28","author":"Evora","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R74-29-20210902","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1053\/j.jvca.2013.12.012","article-title":"Methylene blue: between scylla (meta-analysis) and charybdis (propensity).","volume":"28","author":"Landoni","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R75-29-20210902","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1053\/j.jvca.2013.12.011","article-title":"Methylene blue: the Trojan horse.","volume":"28","author":"Weiner","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R76-29-20210902","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s10620-005-2935-8","article-title":"Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.","volume":"50","author":"Kalambokis","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R77-29-20210902","first-page":"1666","article-title":"Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation.","volume":"22","author":"Laffi","year":"1995","journal-title":"Hepatology"},{"key":"R78-29-20210902","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jclinane.2011.10.010","article-title":"The response to methylene blue in patients with severe hypotension during liver transplantation.","volume":"24","author":"Cheng","year":"2012","journal-title":"J Clin Anesth"},{"key":"R79-29-20210902","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0041-1345(99)00401-7","article-title":"Need for inotropic andor vasopressor drugs during liver transplantation.","volume":"31","author":"Acosta","year":"1999","journal-title":"Transplant Proc"},{"key":"R80-29-20210902","first-page":"54","article-title":"Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation.","volume":"19","author":"Aggarwal","year":"1987","journal-title":"Transplant Proc"},{"key":"R81-29-20210902","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.21381","article-title":"The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation.","volume":"14","author":"Hilmi","year":"2008","journal-title":"Liver Transpl"},{"key":"R82-29-20210902","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/lt.21730","article-title":"Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.","volume":"15","author":"Paugam-Burtz","year":"2009","journal-title":"Liver Transpl"},{"key":"R83-29-20210902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1499-3872(11)60123-9","article-title":"Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience.","volume":"11","author":"Xu","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R84-29-20210902","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s005340100025","article-title":"Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center.","volume":"8","author":"Nanashima","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R85-29-20210902","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clinthera.2005.02.006","article-title":"Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial.","volume":"27","author":"Ponnudurai","year":"2005","journal-title":"Clin Ther"},{"key":"R88-29-20210902","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00534-010-0344-7","article-title":"The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function.","volume":"18","author":"Fukazawa","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R89-29-20210902","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.jvca.2013.03.031","article-title":"Clinical update in liver transplantation.","volume":"27","author":"Valentine","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R91-29-20210902","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1213\/ane.0b013e3181a286fc","article-title":"Vasoplegic syndrome during liver transplantation.","volume":"108","author":"Cao","year":"2009","journal-title":"Anesth Analg"},{"key":"R92-29-20210902","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000539-200204000-00009","article-title":"The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.","volume":"94","author":"Koelzow","year":"2002","journal-title":"Anesth Analg"},{"key":"R93-29-20210902","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/BF01708110","article-title":"Reversal of the haemodynamic features of acute liver failure by methylene blue.","volume":"22","author":"McGinn","year":"1996","journal-title":"Intensive Care Med"},{"key":"R94-29-20210902","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.transproceed.2011.08.108","article-title":"Effect of methylene blue on the hemodynamic instability resulting from liver ischemia and reperfusion in rabbits.","volume":"43","author":"Rosique","year":"2011","journal-title":"Transplant Proc"},{"key":"R95-29-20210902","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/ajrccm.164.5.2009008","article-title":"Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats.","volume":"164","author":"Nunes","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R96-29-20210902","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/gast.1997.v113.pm9247483","article-title":"The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome.","volume":"113","author":"Fallon","year":"1997","journal-title":"Gastroenterology"},{"key":"R97-29-20210902","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MEG.0b013e328014a3bf","article-title":"Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.","volume":"19","author":"Almeida","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R98-29-20210902","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1445-5994.1995.tb01543.x","article-title":"Methylene blue fails to improve hypoxaemia post orthotopic liver transplantation (OLT).","volume":"25","author":"Thomson","year":"1995","journal-title":"Aust N Z J Med"},{"key":"R99-29-20210902","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199410203311617","article-title":"Methylene blue in the hepatopulmonary syndrome.","volume":"331","author":"Rolla","year":"1994","journal-title":"N Engl J Med"},{"key":"R100-29-20210902","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.transproceed.2010.01.003","article-title":"Methylene blue used as a bridge to liver transplantation postoperative recovery: a case report.","volume":"42","author":"Roma","year":"2010","journal-title":"Transplant Proc"},{"key":"R101-29-20210902","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-133-9-200011070-00012","article-title":"Methylene blue improves the hepatopulmonary syndrome.","volume":"133","author":"Schenk","year":"2000","journal-title":"Ann Intern Med"},{"key":"R102-29-20210902","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCMESICMACCPATSSIS International Sepsis Definitions Conference.","volume":"4","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"R103-29-20210902","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"R105-29-20210902","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1084\/jem.176.4.1175","article-title":"N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.","volume":"176","author":"Cobb","year":"1992","journal-title":"J Exp Med"},{"key":"R106-29-20210902","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/jsre.1994.1116","article-title":"Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.","volume":"57","author":"Statman","year":"1994","journal-title":"J Surg Res"},{"key":"R107-29-20210902","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"key":"R108-29-20210902","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00003246-199905000-00025","article-title":"An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.","volume":"27","author":"Grover","year":"1999","journal-title":"Crit Care Med"},{"key":"R109-29-20210902","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.","volume":"32","author":"Lopez","year":"2004","journal-title":"Crit Care Med"},{"key":"R110-29-20210902","first-page":"42","article-title":"Methylene blue as a vasopressor: a meta-analysis of randomised trials.","volume":"15","author":"Pasin","year":"2013","journal-title":"Crit Care Resusc"},{"key":"R111-29-20210902","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000054271","article-title":"Methylene blue inhibits the increase of inducible nitric oxide synthase activity induced by stress and lipopolysaccharide in the medial basal hypothalamus of rats.","volume":"8","author":"Lomniczi","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"R112-29-20210902","first-page":"582","article-title":"The use of methylene blue in the treatment of anaphylactic shock induced by compound 4880: experimental studies in rabbits.","volume":"23","author":"Buzato","year":"2005","journal-title":"Shock"},{"key":"R113-29-20210902","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"R114-29-20210902","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis.","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"R115-29-20210902","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0883-9441(98)90001-6","article-title":"Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.","volume":"13","author":"Andresen","year":"1998","journal-title":"J Crit Care"},{"key":"R116-29-20210902","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1124\/jpet.108.142034","article-title":"Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.","volume":"328","author":"Fernandes","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R117-29-20210902","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/0885066606290671","article-title":"Use of methylene blue in sepsis: a systematic review.","volume":"21","author":"Kwok","year":"2006","journal-title":"J Intensive Care Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000001045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:16:30Z","timestamp":1786112190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201601000-00029"}},"subtitle":["Magic Bullet for Vasoplegia?"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001045","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}